M

MPC Therapeutics

4 employees

MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Cellular rejuvenation
Biotechnology
Mitochondria
Health Care
Immunotherapy
Medical
CAR T cell therapy
Longevity

Date founded

2018

Funding rounds raised

Total raised

$662K

from 2 investors over 2 rounds

M

MPC Therapeutics raised $662K on July 1, 2019

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

M

MPC Therapeutics raised $10K on June 4, 2019

Investors: KICK Ventures

FAQ